vesnarinone has been researched along with Vomiting in 1 studies
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the maximum-tolerated dose, dose-limiting toxicities (DLTs), and pharmacokinetic profile of vesnarinone given once daily in combination with gemcitabine." | 2.69 | Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancer. ( Drengler, RL; Eckhardt, SG; Felton, SA; Garner, AM; Hammond, LA; Hidalgo, M; Mallikaarjun, S; Patnaik, A; Rowinsky, EK; Siu, LL; Tammara, BK; Von Hoff, DD, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patnaik, A | 1 |
| Rowinsky, EK | 1 |
| Tammara, BK | 1 |
| Hidalgo, M | 1 |
| Drengler, RL | 1 |
| Garner, AM | 1 |
| Siu, LL | 1 |
| Hammond, LA | 1 |
| Felton, SA | 1 |
| Mallikaarjun, S | 1 |
| Von Hoff, DD | 1 |
| Eckhardt, SG | 1 |
1 trial available for vesnarinone and Vomiting
| Article | Year |
|---|---|
Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Differentiation; Deoxyc | 2000 |